Subcutaneous Furosemide: A Novel to Euvolemia
- PMID: 38520337
- DOI: 10.1097/CRD.0000000000000689
Subcutaneous Furosemide: A Novel to Euvolemia
Abstract
Furoscix, a subcutaneous pH-neutral formulation of furosemide, obtained US Food and Drug Administration approval in October 2022 for adult patients with New York Heart Association class II and class III chronic heart failure. This approval marks an anticipated potential shift in the traditional management of decongestive therapy in chronic heart failure patients from the confines of the hospital to more accessible outpatient or home-based care. In this review, we will summarize existing evidence regarding the use of subcutaneous furosemide in comparison to both oral and intravenous formulations, highlighting the demonstrable benefits of its application in both outpatient and inpatient settings, and also discuss several factors that may limit its use.
Keywords: Lasix; furoscix; furosemide; heart failure; subcutaneous.
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
Disclosure: The authors declare no conflict of interest.
References
-
- Bozkurt B, Coats AJS, Tsutsui H, et al. Universal Definition and Classification of Heart Failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and writing committee of the Universal Definition of Heart Failure: endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, cardiac society of Australia and New Zealand, and Chinese heart failure association. Eur J Heart Fail. 2021;23:352–380.
-
- Faris RF, Flather M, Purcell H, et al. Diuretics for heart failure. Cochrane Database Syst Rev. 2012;2:CD003838.
-
- Colombo PC, Doran AC, Onat D, et al. Venous congestion, endothelial and neurohormonal activation in acute decompensated heart failure: cause or effect? Curr Heart Fail Rep. 2015;12:215–222.
-
- CardioMEMS Inc. CardioMEMS HF system, PA sensor and delivery system: User’s manual. 2014, May. Available at: https://www.accessdata.fda.gov/cdrh_docs/pdf10/p100045d.pdf . Accessed December 6, 2023.
-
- Ayyadurai P, Alkhawam H, Saad M, et al. An update on the CardioMEMS pulmonary artery pressure sensor. Ther Adv Cardiovasc Dis. 2019;13:1753944719826826.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical